Egolix Tablet 200 mg contains Elagolix Sodium, a potent oral gonadotropin-releasing hormone (GnRH) receptor antagonist. It is specifically formulated for the management of moderate to severe endometriosis-associated pain in women of reproductive age. By providing effective oral therapy, Egolix helps reduce the intensity of dysmenorrhea, non-menstrual pelvic pain, and dyspareunia, improving overall quality of life for patients suffering from endometriosis.

Elagolix works by directly inhibiting GnRH receptors in the pituitary gland, which reduces the secretion of luteinizing hormone (LH) and follicle-stimulating hormone (FSH). This leads to dose-dependent suppression of estrogen production, which is critical in reducing endometriotic lesion growth and associated inflammation. The 200 mg dose offers greater symptom relief for patients with more severe endometriosis-related pain, with the convenience of once or twice daily oral administration depending on medical guidance.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Composition

• Elagolix Sodium: 200 mg per tablet

Indications

Egolix Tablet 200 mg is indicated for:

• Moderate to severe pain associated with endometriosis, including pelvic pain and dysmenorrhea

• Non-menstrual pelvic pain in patients with confirmed endometriosis

• Dyspareunia (pain during sexual intercourse) related to endometriotic lesions

• Patients requiring enhanced symptom control compared to the 150 mg dose

• Women who prefer oral therapy over injectable GnRH agonists

Mechanism of Action

Egolix Tablet 200 mg functions as a GnRH receptor antagonist with a direct and dose-dependent mechanism:

1. GnRH receptor inhibition: Blocks GnRH receptors in the pituitary, preventing LH and FSH secretion.

2. Estrogen suppression: Reduces ovarian estrogen production, which limits growth and inflammation of endometriotic tissue.

3. Symptom relief: Reduces dysmenorrhea, non-menstrual pelvic pain, and dyspareunia.

4. Immediate effect: Unlike GnRH agonists, Egolix provides rapid suppression without an initial hormone flare, improving patient tolerability.

This dose-dependent action allows physicians to tailor therapy based on symptom severity, achieving maximum relief while minimizing adverse effects.

Dosage and Administration

• Route: Oral

• Dosage: As prescribed by a registered physician

The recommended regimen is 200 mg once or twice daily, depending on clinical assessment. Tablets may be taken with or without food, ideally at the same time each day for consistent blood levels. The treatment duration is generally short-term (up to 6 months) to minimize the risk of bone mineral density loss, and patients should undergo periodic monitoring of bone health and hormonal status during therapy.

Benefits of Egolix Tablet 200 mg

• Provides effective relief from moderate to severe endometriosis-related pain

• Reduces dysmenorrhea, pelvic pain, and dyspareunia

• Convenient oral administration improves adherence and avoids injections

• Rapid symptom relief without initial hormonal flare

• Dose-dependent estrogen suppression allows tailored therapy

• Supports improved quality of life and daily functioning for women with endometriosis

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Precautions and Warnings

• Use only under medical supervision

• Contraindicated in pregnancy, severe osteoporosis, or hypersensitivity to Elagolix

• May cause hot flashes, headache, mood changes, irregular bleeding, or decreased bone mineral density

• Not recommended for women planning pregnancy during treatment

• Regular monitoring of bone health, liver function, and overall hormonal status is advised

• Avoid abrupt discontinuation without physician guidance

Storage Conditions

• Store below 30°C in a dry place

• Protect from light and moisture

• Keep out of reach of children

Pharmaceutical Category

GnRH Receptor Antagonist / Endometriosis Therapy / Hormonal Modulator.